Literature DB >> 27383079

Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.

Brandon W Calenda1, Valentin Fuster1, Jonathan L Halperin1, Christopher B Granger2.   

Abstract

Atrial fibrillation (AF) is a complex phenomenon associated with electrical, mechanical, and structural abnormalities of the atria. Ischaemic stroke in AF is only partially understood, but the mechanisms are known to be related to the atrial substrate as well as the atrial rhythm. The temporal dissociation between timing of AF and occurrence of stroke has led to the hypothesis that fibrotic, prothrombotic atrial tissue is an important cause of thrombus formation in patients with AF, independent of the atrial rhythm. Current stroke risk scores are practical, but limited in their capacity to predict stroke risk accurately in individual patients. Stroke prediction might be improved by the addition of emerging risk factors, many of which are expressions of atrial fibrosis. The use of novel parameters, including clinical criteria, biomarkers, and imaging data, might improve stroke risk prediction and inform on optimal treatment for patients with AF and perhaps individuals only at risk of AF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27383079     DOI: 10.1038/nrcardio.2016.106

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  90 in total

1.  Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications.

Authors:  Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2012-05-03

2.  Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

3.  Echocardiographic predictors of left atrial appendage thrombus formation.

Authors:  Srilatha Ayirala; Simi Kumar; David M O'Sullivan; David I Silverman
Journal:  J Am Soc Echocardiogr       Date:  2011-03-25       Impact factor: 5.251

4.  Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation.

Authors:  Jhih-Yuan Shih; Wei-Chuan Tsai; Yao-Yi Huang; Yen-Wen Liu; Chih-Chan Lin; Yu-Shan Huang; Liang-Miin Tsai; Li-Jen Lin
Journal:  J Am Soc Echocardiogr       Date:  2011-02-24       Impact factor: 5.251

5.  Brain natriuretic peptide level on admission predicts recurrent stroke after discharge in stroke survivors with atrial fibrillation.

Authors:  Kensaku Shibazaki; Kazumi Kimura; Junya Aoki; Kenichiro Sakai; Naoki Saji; Junichi Uemura
Journal:  Clin Neurol Neurosurg       Date:  2014-10-05       Impact factor: 1.876

6.  Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Jesper Lindhardsen; Deirdre A Lane; Ole Ahlehoff; Morten Lock Hansen; Jakob Raunsø; Janne Schurmann Tolstrup; Peter Riis Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  Thromb Haemost       Date:  2011-07-20       Impact factor: 5.249

7.  Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.

Authors:  Keitaro Senoo; Gregory Y H Lip; Deirdre A Lane; Harry R Büller; Dipak Kotecha
Journal:  Stroke       Date:  2015-07-23       Impact factor: 7.914

8.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

9.  Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Authors:  V Roldán; F Marín; S Manzano-Fernandez; H Fernández; P Gallego; M Valdés; V Vicente; G Y H Lip
Journal:  Thromb Haemost       Date:  2013-03-21       Impact factor: 5.249

10.  Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Maura Marcucci; Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Harry J G M Crijns; Alfonso Iorio
Journal:  Am J Med       Date:  2014-05-13       Impact factor: 4.965

View more
  24 in total

Review 1.  Bayes Syndrome and Imaging Techniques.

Authors:  Ivan Hernandez-Betancor; Maria Manuela Izquierdo-Gomez; Javier Garcia-Niebla; Ignacio Laynez-Cerdena; Martin Jesus Garcia-Gonzalez; A Barragan-Acea; Jose Luis Irribarren-Sarria; Juan Jose Jimenez-Rivera; Juan Lacalzada-Almeida
Journal:  Curr Cardiol Rev       Date:  2017

Review 2.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

Review 3.  Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines.

Authors:  William F McIntyre; Jeff Healey
Journal:  J Atr Fibrillation       Date:  2017-04-30

4.  Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

Authors:  James A Reiffel
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

5.  Interaction Between Heart Failure and Atrial Fibrillation.

Authors:  Yun Gi Kim
Journal:  Int J Heart Fail       Date:  2022-07-26

6.  Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study.

Authors:  Yun Gi Kim; Jong-Il Choi; Mi-Na Kim; Dong-Hyuk Cho; Suk-Kyu Oh; Hyungdon Kook; Hee-Soon Park; Kwang No Lee; Yong-Soo Baek; Seung-Young Roh; Jaemin Shim; Seong-Mi Park; Wan Joo Shim; Young-Hoon Kim
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

Review 7.  How to detect atrial fibrosis.

Authors:  Juan Lacalzada-Almeida; Javier García-Niebla
Journal:  J Geriatr Cardiol       Date:  2017-03       Impact factor: 3.327

8.  Interatrial block and atrial remodeling assessed using speckle tracking echocardiography.

Authors:  Juan Lacalzada-Almeida; María Manuela Izquierdo-Gómez; Carima Belleyo-Belkasem; Patricia Barrio-Martínez; Javier García-Niebla; Roberto Elosua; Alejandro Jiménez-Sosa; Luis Alberto Escobar-Robledo; Antonio Bayés de Luna
Journal:  BMC Cardiovasc Disord       Date:  2018-02-21       Impact factor: 2.298

9.  Succinate links atrial dysfunction and cardioembolic stroke.

Authors:  Sarah E Nelson; Zsuzsanna Ament; Zoe Wolcott; Robert E Gerszten; W Taylor Kimberly
Journal:  Neurology       Date:  2019-01-23       Impact factor: 9.910

10.  Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation.

Authors:  Rosa B Thorolfsdottir; Gardar Sveinbjornsson; Patrick Sulem; Jonas B Nielsen; Stefan Jonsson; Gisli H Halldorsson; Pall Melsted; Erna V Ivarsdottir; Olafur B Davidsson; Ragnar P Kristjansson; Gudmar Thorleifsson; Anna Helgadottir; Solveig Gretarsdottir; Gudmundur Norddahl; Sridharan Rajamani; Bjarni Torfason; Atli S Valgardsson; Jon T Sverrisson; Vinicius Tragante; Oddgeir L Holmen; Folkert W Asselbergs; Dan M Roden; Dawood Darbar; Terje R Pedersen; Marc S Sabatine; Cristen J Willer; Maja-Lisa Løchen; Bjarni V Halldorsson; Ingileif Jonsdottir; Kristian Hveem; David O Arnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hilma Holm; Kari Stefansson
Journal:  Commun Biol       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.